2020The FASEB JournalRequires access

Differential properties of E prostanoid receptor‐3 and thromboxane prostanoid receptor in activation by prostacyclin to evoke vasoconstrictor response in the mouse renal vasculature

Bin Liu, Ruhui Zeng, Tingting Guo, Yingzhan Zhang, Jing Leng, Jiahui Ge, Gang Yu, Yineng Xu, Yingbi Zhou

Open publisher page 8 citations

Abstract

Abstract Vasomotor reactions of prostacyclin (prostaglandin I 2 ; PGI 2 ) can be collectively modulated by thromboxane prostanoid receptor (TP), E‐prostanoid receptor‐3 (EP3), and the vasodilator I prostanoid receptor (IP). This study aimed to determine the direct effect of PGI 2 on renal arteries and/or the whole renal vasculature and how each of these receptors is involved. Experiments were performed on vessels or perfused kidneys of wild‐type mice and/or mice with deficiency in TP (TP −/− ) and/or EP3. Here we show that PGI 2 did not evoke relaxation, but instead resulted in contraction of main renal arteries (from ~0.001‐0.01 µM) or reduction of flow in perfused kidneys (from ~1 µM); either of them was reversed into a dilator response in TP −/− /EP3 −/− counterparts. Also, we found that in renal arteries although it has a lesser effect than TP −/− on the maximal contraction to PGI 2 (10 µM), EP3 −/− but not TP −/− resulted in relaxation to the prostanoid at 0.01‐1 µM. Meanwhile, TP −/− only significantly reduced the contractile activity evoked by PGI 2 at ≥0.1 µM. These results demonstrate that PGI 2 may evoke an overall vasoconstrictor response in the mouse renal vasculature, reflecting activities of TP and EP3 outweighing that of the vasodilator IP. Also, our results suggest that EP3, on which PGI 2 can have a potency similar to that on IP, plays a major role in the vasoconstrictor effect of the prostanoid of low concentrations (≤1 µM), while TP, on which PGI 2 has a lower potency but higher efficacy, accounts for a larger part of its maximal contractile activity.

About this research paper

What this paper is about

Abstract Vasomotor reactions of prostacyclin (prostaglandin I 2 ; PGI 2 ) can be collectively modulated by thromboxane prostanoid receptor (TP), E‐prostanoid receptor‐3 (EP3), and the vasodilator I prostanoid receptor (IP). This study aimed to determine the direct effect of PGI 2 on renal arteries and/or the whole renal vasculature and how each of these receptors is involved. Experiments were performed on vessels or perfused kidneys of wild‐type mice and/or mice with deficiency in TP (TP −/− ) and/or EP3. Here we show that PGI 2 did not evoke relaxation, but instead resulted in contraction of main renal arteries (from ~0.001‐0.01 µM) or reduction of flow in perfused kidneys (from ~1 µM); either of them was reversed into a dilator response in TP −/− /EP3 −/− counterparts. Also, we found that in renal arteries although it has a lesser effect than TP −/− on the maximal contraction to PGI 2 (10 µM), EP3 −/− but not TP −/− resulted in relaxation to the prostanoid at 0.01‐1 µM. Meanwhile, TP −/− only significantly reduced the contractile activity evoked by PGI 2 at ≥0.1 µM. These results demonstrate that PGI 2 may evoke an overall vasoconstrictor response in the mouse renal vasculature, reflecting activities of TP and EP3 outweighing that of the vasodilator IP. Also, our results suggest that EP3, on which PGI 2 can have a potency similar to that on IP, plays a major role in the vasoconstrictor effect of the prostanoid of low concentrations (≤1 µM), while TP, on which PGI 2 has a lower potency but higher efficacy, accounts for a larger part of its maximal contractile activity.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract Vasomotor reactions of prostacyclin (prostaglandin I 2 ; PGI 2 ) can be collectively modulated by thromboxane prostanoid receptor (TP), E‐prostanoid receptor‐3 (EP3), and the vasodilator I prostanoid receptor (IP). This study aimed to determine the direct effect of PGI 2 on renal arteries and/or the whole renal vasculature and how each of these receptors is involved. Experiments were performed on vessels or perfused kidneys of wild‐type mice and/or mice with deficiency in TP (TP −/− ) and/or EP3. Here we show that PGI 2 did not evoke relaxation, but instead resulted in contraction of main renal arteries (from ~0.001‐0.01 µM) or reduction of flow in perfused kidneys (from ~1 µM); either of them was reversed into a dilator response in TP −/− /EP3 −/− counterparts. Also, we found that in renal arteries although it has a lesser effect than TP −/− on the maximal contraction to PGI 2 (10 µM), EP3 −/− but not TP −/− resulted in relaxation to the prostanoid at 0.01‐1 µM. Meanwhile, TP −/− only significantly reduced the contractile activity evoked by PGI 2 at ≥0.1 µM. These results demonstrate that PGI 2 may evoke an overall vasoconstrictor response in the mouse renal vasculature, reflecting activities of TP and EP3 outweighing that of the vasodilator IP. Also, our results suggest that EP3, on which PGI 2 can have a potency similar to that on IP, plays a major role in the vasoconstrictor effect of the prostanoid of low concentrations (≤1 µM), while TP, on which PGI 2 has a lower potency but higher efficacy, accounts for a larger part of its maximal contractile activity.

Key concepts: Prostanoid, Prostacyclin, Endocrinology, Internal medicine, Thromboxane, Vasodilation, Thromboxane receptor, Receptor

Related papers

Back to paper searchBrowse research topicsOriginal source
Differential properties of E prostanoid receptor‐3 and thromboxane prostanoid receptor in activation by prostacyclin to evoke vasoconstrictor response in the mouse renal vasculature — Research Paper | ScholarLens